These results suggest that NaHS protected the kidneys during urinary-derived sepsis by inhibiting NF-κB, reducing the level of TNF-α and increasing the level of IL-10, thereby reducing inflammation in urinary-derived sepsis. The gene discussed is NFKB1; the disease is Sepsis.